Skip to content

Distant Vision improvement with Ayurvedic medicine Vishamajwarantak lauha in simple myopia

A Randomized Controlled Clinical Trial to assess Efficacy of Vishamajwarantak Lauha with Optical Correction in Prathama Patalagata Timira with reference to Simple Myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038027
Enrollment
72
Registered
2021-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

None listed

Sponsors

Dr Rutuja Bhalekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with classical features of Prathama patalagata Timira and Simple Myopia. 2.Patients having dioptre power up to -3.00D. 3.Patients of either sex within the age group of 18-30 years of age.

Exclusion criteria

Exclusion criteria: 1. Dwitiya, Tritiya and Chaturtha Patalagata Timira. 2. Patients with more than -3.00D of vision. 3. Pathological myopia or Progressive myopia. 4. Refractive errors like Hypermetropia, Astigmatism and other ocular pathologies. 5. Patients with systemic diseases like Diabetes mellitus, Hypertension, TB. 6. Patientâ??s below 18 years and above 35 years of age. 7. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Vishamajwarantak lauha is effective in Prathama patalagata Timira with reference to Simple MyopiaTimepoint: Follow up on 0th,7th,14th,21st,28th and 35th day

Secondary

MeasureTime frame
Vishamajwarantak lauha is not effective in Prathama patalagata Timira with reference to Simple MyopiaTimepoint: Follow up on 0th,7th,14th,21st,28th and 35th day

Countries

India

Contacts

Public ContactDr Dipti Nene

YMT Ayurvedic Medical college and hospital

dipti.nene@gmail.com9987005997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026